Last Updated : October 17, 2024
Details
FilesGeneric Name:
dabrafenib trametinib
Project Status:
Pending
Therapeutic Area:
Head and neck cancer
Call for patient/clinician input open:
Brand Name:
TBC
Project Line:
Reimbursement Review
Project Number:
PX0373-000
Call for patient/clinician input closed:
Submission Type:
Non-sponsored Submission
Indications:
Indicated for BRAF V600E mutant anaplastic thyroid cancer.
Files
Last Updated : October 17, 2024